<DOC>
	<DOCNO>NCT02321189</DOCNO>
	<brief_summary>Choroidal thickness represent blood-flowing eye . The investigator detect choroidal thickness young participant use SD-OCT see effect Resveratrol Based Nutritional Supplement Choroidal Thickness .</brief_summary>
	<brief_title>The Effect Resveratrol Based Nutritional Supplement Choroidal Thickness</brief_title>
	<detailed_description>34 young , healthy participant include study ; They randomly divide two group age gender matched.100 mg Longevinex® capsule give study group 100mg placebo capsule control group . All participant underwent OCT scan spectral domain optic coherence tomography ( SD-OCT ) baseline 1 h follow Longevinex® placebo administration . The choroidal thickness measure manually Heidelberg Eye explore software ( version 5.3.3.0 , Heidelberg Engineering ) vertical line retinal pigment epithelial layer .</detailed_description>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Resveratrol</mesh_term>
	<criteria>1 . Male female patient 2328 year age . nonsmoker . 2 . Patients consider healthy basis electrocardiogram ( ECG ) , clinical laboratory safety test ( haematology , plasma biochemistry , urinalysis hepatitis B , hepatitis C HIV serology ) perform screen . 3 . Avoid ingest grapefruit , grapefruit juice grapefruit juice contain product , herbalbased nutrient supplement prescribe medication ( grapefruit , cranberry , blueberry product , peanut peanut butter , grape grape product , red wine ) period time . 4. patient abstain alcoholcontaining beverage least two day prior study . 1 . Uncontrolled Blood pressure exceed diastolic pressure 100 mm Hg ( sit ) screen period uncontrolled diabetes mellitus 2 . Participation another simultaneous medical investigation trial Renal failure require dialysis renal transplant liver dysfunction History disease , finding give reasonable suspicion disease condition contraindicate use investigational drug , might affect interpretation result study , render subject high risk treatment complication . 3 . IOP 30 mmHg . 4 . Any previous retinal laser photocoagulation study eye treatment naive . Any previous intravitreal injection study eye ( triamcinolone ) treatment naive . 5 . Any previous vitrectomy study eye ( posterior anterior associate vitreous loss cataract surgery ) . 6 . Intracapsular cataract extraction ( posterior capsule need present ) . 7 . Aphakia absence posterior capsule study eye , Structural damage center macula study eye preexist CRVO likely preclude improvement visual acuity follow resolution macular edema , include atrophy retinal pigment epithelium , subretinal fibrosis , laser scar ( ) .</criteria>
	<gender>All</gender>
	<minimum_age>23 Years</minimum_age>
	<maximum_age>28 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>